Spinoff company receives a boost worth millions

“We use what are known as non-coding ribonucleic acids (RNAs) to diagnose and treat heart conditions such as cardiac insufficiency,“ says Professor Thomas Thum, founder of a Hannover Medical School (MHH) spinoff company called... [more]

Post-heart-attack cellular therapy: expectations unfulfilled

Following a major heart attack, patients’ risk of developing a persistent weakening of the heart muscle (i.e. cardiac insufficiency) remains just as high as it was – despite cellular therapy. Based on a trial entitled BOOST... [more]

REBIRTH sets learning in motion

Children and adolescents are exercising less and less. To boost awareness of preventive action among parents and in schools, Hannover Medical School (MHH) is launching a two-year motion study called ‘REBIRTH active school’ in... [more]

Welcome to REBIRTH

With the enthusiastic support of six important partner institutions, Hannover Medical School (MHH) in 2006 has established a Cluster of Excellence in the area of Regenerative Biology and Reconstructive Therapies, acronym REBIRTH. 

The goal of the Excellence Initiative is to strengthen cutting-edge research in Germany and to improve its international competitiveness. Outstanding projects are funded as Clusters of Excellence which focus on the research potential at university locations in Germany and, hence, strengthen their international visibility.